PRO-CURE THERAPEUTICS

pro-cure-therapeutics-logo

Pro-Cure Therapeutics Limited is focused on developing drugs targeted against cancer stem cells. The company has identified targets for new classes of cancer drugs that may fundamentally change the management of cancer. They are developing a pipeline of therapeutic candidates against these targets, starting in prostate cancer and then expanding into other tumour types.

#SimilarOrganizations #Financial #More

PRO-CURE THERAPEUTICS

Industry:
Biotechnology Health Diagnostics Medical Pharmaceutical

Founded:
2001-01-01

Address:
York, York, United Kingdom

Country:
United Kingdom

Status:
Active

Contact:
44 1904 435 125

Email Addresses:
[email protected]

Total Funding:
2.24 M USD

Technology used in webpage:
Google Tag Manager Google Analytics Nginx Pound Sterling Typekit Google Analytics Classic ShareThis Google Plus One Platform SEO_H2 Google Plus One Button


Similar Organizations

ascentawits-logo

Ascentawits

Ascentawits focuses on developing small molecule targeted conjugated anti-tumor drugs.

blood-assay-solutions-logo

Blood Assay Solutions

Blood Assay Solutions is expertise in developing specific assays that help in evaluating bioactivity on primary cells.

celator-pharmaceuticals-logo

Celator Pharmaceuticals

Celator Pharmaceuticals is a biopharmaceutical company developing therapies to treat cancer, using the drug ratio technology platform.

Investors List

maven-capital-partners_image

Maven Capital Partners

Maven Capital Partners investment in Venture Round - Pro-Cure Therapeutics

yfm-venture-finance_image

SMH Venture Finance Limited

SMH Venture Finance Limited investment in Venture Round - Pro-Cure Therapeutics

yorkshire-cancer-research_image

Yorkshire Cancer Research

Yorkshire Cancer Research investment in Venture Round - Pro-Cure Therapeutics

yorkshire-cancer-research_image

Yorkshire Cancer Research

Yorkshire Cancer Research investment in Venture Round - Pro-Cure Therapeutics

white-rose-technology-seedcorn-fund_image

White Rose Technology Seedcorn Fund

White Rose Technology Seedcorn Fund investment in Venture Round - Pro-Cure Therapeutics

More informations about "Pro-Cure Therapeutics"

Pro-cure Therapeutics - VentureRadar

" Pro-Cure Therapeutics is focused on developing drugs targeted against cancer stem cells. The company has identified targets for new classes of cancer drugs that may fundamentally โ€ฆSee details»

Pro-Cure Therapeutics - Funding, Financials, Valuation & Investors

Pro-Cure Therapeutics is focused on developing drugs targeted against cancer stem cells. New. Resources. Advanced Search. Start Free Trial . Talk With Sales. Pricing. Log In. Log In. โ€ฆSee details»

Pro-Cure Therapeutics - LinkedIn

Pro-Cure Therapeutics | 15 followers on LinkedIn. ... Gentronix, Part of Scantox Group Research Services Alderley Edge, CheshireSee details»

Pro-Cure Therapeutics - Company Profile - Tracxn

Pro-Cure Therapeutics - Engages in the discovery and development of drugs that are targeted against cancer stem cells. This company is not active anymore. Raised a total funding of โ€ฆSee details»

Pro-Cure Therapeutics - Overview, News & Similar companies

Pro-Cure Therapeutics Limited is focused on developing drugs targeted against cancer stem cells. The company has identified targets for new classes of cancer drugs that may fundamentally โ€ฆSee details»

Pro-Cure Therapeutics funding & investors - Tracxn

Mar 21, 2025 Pro-Cure Therapeutics has raised a total funding of $1.95M over 1 round from 2 investors. Investors include White Rose Technology Seedcorn Fund and Yorkshire Cancer โ€ฆSee details»

Pro-Cure and Adjuvantix to develop vaccine targeting cancer stem โ€ฆ

The collaboration will bring together Pro-Cureโ€™s proprietary CSC targets and expertise in prostate cancer with Adjuvantixโ€™s expertise in vaccine discovery and development.Mick McLean, CEO โ€ฆSee details»

Pro-Cure Therapeutics - Golden

Canonical knowledge wiki about Pro-Cure Therapeutics. Create. Log in. Sign up. Golden has been acquired by ComplyAdvantage. Read about it here โ€Œ Pro-Cure Therapeutics. Overview โ€ฆSee details»

Pro-Cure Therapeutics Limited - Pharmaceuticals & Healthcare

Pro-Cure Therapeutics Limited - Pharmaceuticals & Healthcare - Deals and Alliances Profile Published by GlobalData at researchbeam.com [Report Price $250] 17 Pages โ€ฆSee details»

Pro-Cure Therapeutics - Products, Competitors, Financials, โ€ฆ

Pro-Cure Therapeutics provides tools for scientific research with a focus on behavioral neuroscience and lab equipment. The company offers products including automated mazes โ€ฆSee details»

Pro-cure Therapeutics | VentureRadar

Macrophage Pharma United Kingdom Closed Down (Assumed) Macrophage Pharma is developing a highly novel class of small molecule therapeutics which modulate immune โ€ฆSee details»

Investment hope of York drugs firm Pro-Cure Therapeutics

May 25, 2010 A YORK-based drug development company is seeking investment to do more clinical trials on possible treatments for prostate cancer.See details»

Pro-Cure Therapeutics Limited - Mergers and Acquisitions (MandA ...

Pro-Cure Therapeutics Limited - Mergers and Acquisitions (MandA), Partnerships and Alliances and Investment Report Published by MarketLine at researchbeam.com [Report Price $350] 27 โ€ฆSee details»

Pro-Cure Therapeutics - Crunchbase

Pro-Cure Therapeutics is focused on developing drugs targeted against cancer stem cells. New. Resources. Advanced Search. Start Free Trial . Talk With Sales. Pricing. Log In. Log In. โ€ฆSee details»

Probacure

We support early-stage therapeutics and vaccines. In the early stages, getting the resources to move your project or company forward can make or break your chances. ... We've been โ€ฆSee details»

Pro-Cure Therapeutics - Updates, News, Events, Signals & Triggers

Pro-Cure Therapeutics is focused on developing drugs targeted against cancer stem cells.See details»

Pro-Cure Therapeutics Culture - Comparably

Learn about Pro-Cure Therapeutics' culture, see what work's like, read reviews, and find job opportunities.See details»

Pro-Cure Therapeutics_Pro-Cure Therapeutics_ๆฅๅฎ็ฝ‘

Pro-Cure seeks alliances with companies to develop new therapeutics against these exciting new targets. Pro-Cure is pursuing MAb approaches to selected targets but targets are also โ€ฆSee details»

IceCure Announces Positive FDA Development: Understanding on โ€ฆ

3 days ago CAESAREA, Israel, April 30, 2025 /PRNewswire/ -- IceCure Medical Ltd. (NASDAQ: ICCM) ("IceCure", "IceCure Medical" or the "Company"), developer of minimally-invasive โ€ฆSee details»

Pro-Cure Therapeutics - Tech Stack, Apps, Patents & Trademarks

Organization. Pro-Cure Therapeutics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. ... Pro-Cure Therapeutics is โ€ฆSee details»

linkstock.net © 2022. All rights reserved